The latest market analysis forecasts a significant upsurge in the global intracranial aneurysm treatment market, with a robust Compound Annual Growth Rate (CAGR) of 8.8% anticipated between 2022 and 2032. According to projections, the market is poised to escalate from USD 1.2 billion in 2022 to an estimated USD 2.56 billion by 2032.
The burgeoning market growth is primarily attributed to the escalating prevalence of intracranial aneurysms worldwide. With the advent of cutting-edge medical technology, innovative treatment approaches are becoming increasingly available, fostering the demand for advanced therapies to address this potentially life-threatening vascular disorder.
Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-15291
Intracranial aneurysms, characterized by the abnormal bulging of blood vessels in the brain, pose a significant health risk due to their potential to rupture and cause severe hemorrhagic stroke. The rising incidence of this condition underscores the urgent need for effective and advanced treatment modalities.
Advancements in medical technology have paved the way for novel treatment options, including minimally invasive endovascular procedures and improved surgical techniques. These innovations not only enhance patient outcomes but also reduce recovery times and associated healthcare costs. As a result, the demand for advanced therapies is expected to surge, driving the market’s impressive growth trajectory.
Furthermore, increased awareness and early diagnosis of intracranial aneurysms are contributing to the market expansion. Healthcare providers and stakeholders are investing in research and development to introduce safer and more effective treatments, further bolstering market growth.
The projected market expansion presents significant opportunities for key industry players to innovate and expand their product portfolios. Collaboration between medical device manufacturers, healthcare providers, and research institutions will be instrumental in developing cutting-edge solutions that address the growing global demand for intracranial aneurysm treatments.
As the global intracranial aneurysm treatment market continues to evolve, stakeholders are urged to stay abreast of the latest technological advancements and market trends to leverage the burgeoning opportunities and contribute to improving patient care worldwide.
Key Takeaways:
- The type category has three major segments, Surgical Clipping, Endovascular Coiling, and Flow Diverters. The endovascular coiling segment dominates the market while holding a market share of 85.3% of the global share.
- The minimally invasive techniques go through the catheter to locate the aneurysm in the brain. Growing hypertension among the geriatric population leads people to a higher chance of brain aneurysms and other diseases.
- The end user category is dominated by the hospital segment, holding 89.5% of the global market. The segment grows at a promising CAGR of 8.9% through the forecast period, attributed to application of technologically advanced tools in operation theaters and intensive care units along with increased number of healthcare units.
- North America holds 27% of the global share in the global intracranial aneurysm market in 2022. The growing intracranial aneurysm market in the North American region is attributed to the growing healthcare facilities, government investments, and the rising cases of brain aneurysms.
- Asia Pacific region is anticipated to thrive at the highest CAGR of 12.7% through 2032. Presence of emerging economies like India and China that are investing huge capital in building their healthcare infrastructure, advancing and making it tech-enabled.
“The Intracranial aneurysm market analysis states that the use of new platforms like Artificial intelligence, big data, and the internet of things (IOT) are integrating with the treatment solutions. Countries such as the U.S., the U.K., and Germany have witnessed a high prevalence of intracranial aneurysms in recent years. Neuro Intervention India states that approximately 6.0 million people in the U.S. develop an unruptured intracranial aneurysm. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices, fueling the demand for intracranial aneurysm treatment solutions” says a Future Market Insights analyst.
Checkout Now to Access Competitive Analysis: https://www.futuremarketinsights.com/checkout/15291
Competitive Landscape:
The Intracranial aneurysm market has various key competitors that focus on expanding healthcare centers with advanced technology. The key competitors understand and focus on new techniques that are aneurysm-specific and target wall healing and blood prevention. This makes the competitive landscape more dynamic and versatile, owing to the expansion of the intracranial aneurysm market.
The key competitors flourishing in the growth of intracranial aneurysm treatment solutions are Medtronic, Microport Scientific Corporation, B. Braun, Stryker, Johnson and Johnson Services Inc., Microvention Inc., and Codman Neuro (Integra Lifesciences).
Recent Developments:
- MicroPort Scientific Corporation has introduced new therapies for neurovascular intervention that resolve potential issues related to brain aneurysms, offering specific tools to surgeons. This fuels the sales of intracranial aneurysm treatment solutions.
- Stryker has added the neuroform atlas stent system that is further used in conjunction with metal coils that help in packing Aneurysms (week walls and blood vessel scar) in the brain. This is anticipated to help multiple surgeons across the globe.
A Full Report Analysis: https://www.futuremarketinsights.com/reports/intracranial-aneurysm-market
Intracranial aneurysm Market by Segmentation:
By Type Outlook:
- Surgical Clipping
- Endovascular Coiling
- Flow Diverters
By Application Outlook:
- Hospitals
- Clinics
- Others
By Region:
- North America
- Latin America
- Europe
- Middle East and Africa
- South Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube